{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:23:09Z","timestamp":1762543389733,"version":"3.37.3"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Sarcopenia is associated with oncological outcomes in various types of cancer. However, the impact of sarcopenia in renal cell carcinoma with inferior vena cava thrombus remains unclear. We herein evaluated the prognostic significance of sarcopenia for renal cell carcinoma with inferior vena cava thrombus following nephrectomy and thrombectomy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients who underwent nephrectomy and thrombectomy for renal cell carcinoma with inferior vena cava thrombus at our department between 2004 and 2019 were retrospectively evaluated. Their sarcopenic status, determined by sex, body mass index and skeletal muscle index, was calculated using pre-surgical radiographic imaging. We compared the post-operative cancer-specific survival and overall survival, surgical data and duration of post-operative hospitalization of sarcopenic and non-sarcopenic patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Out of 83 patients, 54 (65%) were sarcopenic. Sarcopenic patients had significantly shorter cancer-specific survival (median: 33.3\u00a0months vs. not reached, P\u00a0=\u00a00.0323) and overall survival (32.0\u00a0months vs. not reached, P\u00a0=\u00a00.0173) than non-sarcopenic patients. Furthermore, multivariate analyses showed that sarcopenia was an independent factor for cancer-specific survival (hazard ratio: 2.76, P\u00a0=\u00a00.0212) and overall survival (hazard ratio: 2.93, P\u00a0=\u00a00.014). The incidence rate of surgical complications (any grade: 35.2% vs. 27.6%, P\u00a0=\u00a00.482; grades\u00a0\u2265\u00a03: 7.4% vs. 10.3%, P\u00a0=\u00a00.648) or duration of post-operative hospitalization (median: 11 vs. 10\u00a0days, P\u00a0=\u00a00.148) was not significantly different between sarcopenic and non-sarcopenic patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In conclusion, this study showed that sarcopenia was an independent prognostic factor for renal cell carcinoma with inferior vena cava thrombus after nephrectomy and tumor thrombectomy. Thus, sarcopenia evaluation can be utilized as an effective prognosticator of post-operative survival.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jjco\/hyaa275","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T20:24:09Z","timestamp":1611001449000},"page":"819-825","source":"Crossref","is-referenced-by-count":12,"title":["Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus"],"prefix":"10.1093","volume":"51","author":[{"given":"Shun","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5146-656X","authenticated-orcid":false,"given":"Hiroki","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-0943","authenticated-orcid":false,"given":"Toshio","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunenori","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University Medical Center East, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ishiyama","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpei","family":"Iizuka","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University Medical Center East, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Women\u2019s Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"2021043016555831200_ref1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.urolonc.2008.11.017","article-title":"Renal cell carcinoma with inferior vena cava thrombus: the Hacettepe experience","volume":"28","author":"Yazici","year":"2010","journal-title":"Urol Oncol"},{"key":"2021043016555831200_ref2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1464-410X.2004.04897.x","article-title":"The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus","volume":"94","author":"Blute","year":"2004","journal-title":"BJU Int"},{"key":"2021043016555831200_ref3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.juro.2007.05.134","article-title":"Prognostic factors for renal cell carcinoma with tumor thrombus extension","volume":"178","author":"Klatte","year":"2007","journal-title":"J Urol"},{"key":"2021043016555831200_ref4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/01.ju.0000104672.37029.4b","article-title":"Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?","volume":"171","author":"Kim","year":"2004","journal-title":"J Urol"},{"key":"2021043016555831200_ref5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00000658-198909000-00014","article-title":"Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival","volume":"210","author":"Skinner","year":"1989","journal-title":"Ann Surg"},{"key":"2021043016555831200_ref6","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.urology.2014.05.078","article-title":"Surgical outcomes after cytoreductive nephrectomy with inferior vena cava thrombectomy","volume":"84","author":"Westesson","year":"2014","journal-title":"Urology"},{"key":"2021043016555831200_ref7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10147-017-1232-9","article-title":"Oncological outcomes after cytoreductive nephrectomy for patients with metastatic renal cell carcinoma with inferior vena caval tumor thrombus","volume":"23","author":"Miyake","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"2021043016555831200_ref8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cncr.23518","article-title":"Renal cell cancer stage migration: analysis of the National Cancer Data Base","volume":"113","author":"Kane","year":"2008","journal-title":"Cancer"},{"key":"2021043016555831200_ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2008.10.002","article-title":"Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base","volume":"13","author":"Nese","year":"2009","journal-title":"Ann Diagn Pathol"},{"key":"2021043016555831200_ref10","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.juro.2007.01.039","article-title":"Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup","volume":"177","author":"Haferkamp","year":"2007","journal-title":"J Urol"},{"key":"2021043016555831200_ref11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.eururo.2008.07.053","article-title":"Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma","volume":"55","author":"Wagner","year":"2009","journal-title":"Eur Urol"},{"key":"2021043016555831200_ref12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.eururo.2010.10.001","article-title":"Prognostic impact of the 2009 UICC\/AJCC TNM staging system for renal cell carcinoma with venous extension","volume":"59","author":"Mart\u00ednez-Salamanca","year":"2011","journal-title":"Eur Urol"},{"key":"2021043016555831200_ref13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ejso.2012.03.006","article-title":"Prognostic significance of tumor extension into venous system in patients undergoing surgical treatment for renal cell carcinoma with venous tumor thrombus","volume":"38","author":"Miyake","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"2021043016555831200_ref14","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/iju.12123","article-title":"Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: single-center experience","volume":"20","author":"Kondo","year":"2013","journal-title":"Int J Urol"},{"key":"2021043016555831200_ref15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-5347(05)63931-6","article-title":"Surgical techniques for treating a renal neoplasm invading the inferior vena cava","volume":"169","author":"Vaidya","year":"2003","journal-title":"J Urol"},{"key":"2021043016555831200_ref16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.eururo.2007.05.009","article-title":"A critical analysis of surgery for kidney cancer with vena cava invasion","volume":"52","author":"Kirkali","year":"2007","journal-title":"Eur Urol"},{"key":"2021043016555831200_ref17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"2021043016555831200_ref18","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.05.001","article-title":"Sarcopenia in urologic oncology: identification and strategies to improve patient outcomes","author":"Robertson","year":"2020","journal-title":"Urol Oncol"},{"key":"2021043016555831200_ref19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","article-title":"Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review","volume":"57","author":"Shachar","year":"2016","journal-title":"Eur J Cancer"},{"key":"2021043016555831200_ref20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/bjc.2017.149","article-title":"Subcutaneous adiposity is an independent predictor of mortality in cancer patients","volume":"117","author":"Ebadi","year":"2017","journal-title":"Br J Cancer"},{"key":"2021043016555831200_ref21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.urolonc.2020.02.014","article-title":"Sarcopenia as a predictor of postoperative outcomes after urologic oncology surgery: a systematic review and meta-analysis","volume":"38","author":"Guo","year":"2020","journal-title":"Urol Oncol"},{"key":"2021043016555831200_ref22","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.clgc.2016.08.004","article-title":"Postoperative changes in skeletal muscle mass predict survival of patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy","volume":"15","author":"Fukushima","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"2021043016555831200_ref23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/end.2015.0492","article-title":"Does sarcopenia impact complications and overall survival in patients undergoing radical nephrectomy for stage III and IV kidney cancer?","volume":"30","author":"Peyton","year":"2016","journal-title":"J Endourol"},{"key":"2021043016555831200_ref24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11523-016-0430-0","article-title":"Sarcopenia and the modified Glasgow prognostic score are significant predictors of survival among patients with metastatic renal cell carcinoma who are receiving first-line Sunitinib treatment","volume":"11","author":"Ishihara","year":"2016","journal-title":"Target Oncol"},{"key":"2021043016555831200_ref25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11523-018-0600-3","article-title":"Effect of changes in skeletal muscle mass on oncological outcomes during first-line Sunitinib therapy for metastatic renal cell carcinoma","volume":"13","author":"Ishihara","year":"2018","journal-title":"Target Oncol"},{"key":"2021043016555831200_ref26","doi-asserted-by":"crossref","first-page":"339.e17","DOI":"10.1016\/j.urolonc.2015.01.011","article-title":"Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma","volume":"33","author":"Sharma","year":"2015","journal-title":"Urol Oncol"},{"key":"2021043016555831200_ref27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.juro.2015.08.072","article-title":"Decreased skeletal muscle mass is associated with an increased risk of mortality after radical nephrectomy for localized renal cell cancer","volume":"195","author":"Psutka","year":"2016","journal-title":"J Urol"},{"key":"2021043016555831200_ref28","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1038\/s41598-017-07955-6","article-title":"Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients","volume":"7","author":"Gu","year":"2017","journal-title":"Sci Rep"},{"key":"2021043016555831200_ref29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clgc.2017.01.022","article-title":"Prediction of Everolimus toxicity and prognostic value of skeletal muscle index in patients with metastatic renal cell carcinoma","volume":"15","author":"Auclin","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"2021043016555831200_ref30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.juro.2015.08.071","article-title":"Prognostic significance of sarcopenia in patients with metastatic renal cell carcinoma","volume":"195","author":"Fukushima","year":"2016","journal-title":"J Urol"},{"key":"2021043016555831200_ref31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00292-010-1349-3","article-title":"2010 TNM system: on the 7th edition of TNM classification of malignant tumors","volume":"31","author":"Wittekind","year":"2010","journal-title":"Pathologe"},{"key":"2021043016555831200_ref32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1464-410X.1987.tb04832.x","article-title":"Surgical treatment of renal cancer with vena cava extension","volume":"59","author":"Neves","year":"1987","journal-title":"Br J Urol"},{"key":"2021043016555831200_ref33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"2021043016555831200_ref34","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J Appl Physiol (1985)"},{"key":"2021043016555831200_ref35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"2021043016555831200_ref36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"2021043016555831200_ref37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.urology.2013.04.054","article-title":"Results of a national population-based study of outcomes of surgery for renal tumors associated with inferior vena cava thrombus","volume":"82","author":"Toren","year":"2013","journal-title":"Urology"},{"key":"2021043016555831200_ref38","doi-asserted-by":"crossref","first-page":"388.e1","DOI":"10.1016\/j.urolonc.2015.04.010","article-title":"Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus","volume":"33","author":"Haddad","year":"2015","journal-title":"Urol Oncol"},{"key":"2021043016555831200_ref39","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eururo.2013.10.029","article-title":"Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience","volume":"66","author":"Abel","year":"2014","journal-title":"Eur Urol"},{"key":"2021043016555831200_ref40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01741856","article-title":"Interleukin-6 and renal cell cancer: production, regulation, and growth effects","volume":"35","author":"Koo","year":"1992","journal-title":"Cancer Immunol Immunother"},{"key":"2021043016555831200_ref41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0014-5793(89)80805-1","article-title":"Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas","volume":"250","author":"Miki","year":"1989","journal-title":"FEBS Lett"},{"key":"2021043016555831200_ref42","first-page":"4653","article-title":"Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence","volume":"9","author":"Trikha","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2021043016555831200_ref43","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/annonc\/mdx810","article-title":"Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy","volume":"29","author":"Baracos","year":"2018","journal-title":"Ann Oncol"},{"key":"2021043016555831200_ref44","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/bjs.9893","article-title":"Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies","volume":"102","author":"Levolger","year":"2015","journal-title":"Br J Surg"},{"key":"2021043016555831200_ref45","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/cncr.28798","article-title":"Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality","volume":"120","author":"Psutka","year":"2014","journal-title":"Cancer"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/51\/5\/819\/37653878\/hyaa275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/51\/5\/819\/37653878\/hyaa275.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T16:56:34Z","timestamp":1619801794000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/51\/5\/819\/6131387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,2,9]]},"published-print":{"date-parts":[[2021,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyaa275","relation":{},"ISSN":["1465-3621"],"issn-type":[{"type":"electronic","value":"1465-3621"}],"subject":[],"published-other":{"date-parts":[[2021,5]]},"published":{"date-parts":[[2021,2,9]]}}}